semaglutide poster Semaglutide- for weight loss in obesity Semaglutide Diabetes Drug Molecule #3

Guerra V, Ologun GO, Haydu LE, Keung E, Burton EM, Tawbi H, Wierda WG, Davies MA , Wargo JA, Ferrajoli A

Hamann CR, Chung C, Kaffenberger BH

Unlike SGLT2 inhibitors (another class of diabetes medications), semaglutide does not have diuretic properties that would directly increase urine output

Phosphorylated RIPK3 subsequently recruits and phosphorylates MLKL, which translocates to the plasma membrane to form pore complexes, disrupting membrane integrity

Thermo Fisher Scientific) containing 10% FBS and 1 P/S

They called for greater efforts to include diverse populations in future trials, with longer-time follow-ups beyond 26 weeks